Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Suppressing certain hormones might help prevent prostate cancer.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Finasteride reduces prostate size and PSA levels in young patients.

Higher cholesterol levels increase aggressive prostate cancer risk.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Certain drugs that block specific enzymes can help treat prostate diseases.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Micrografts improve hair density and thickness without side effects.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Early hair loss may indicate prostate issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Finasteride does not prevent bladder cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Higher DHT in male baldness may protect against prostate cancer.

Smaller finasteride particles increase effectiveness in treating hair loss.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

New steroids were effective in blocking male hormone receptors in hamster prostates.

A new compound was effective for imaging prostate cancer in rats.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.